Table 1.
Baseline characteristics of patients undergoing TEPS for CTPV
| Parameter | Mean ± SD,median (IQR) or absolute (percentage) |
|---|---|
| Sex | |
| Male | 14 (63.6%) |
| Female | 8 (36.4%) |
| Etiology | |
| Liver cirrhosis | 20 (90.9%) |
| Non-cirrhosis | 2(9.1%) |
| Age (years) | 55.27 ± 12.10 |
| RBC (× 1012/L) | 3.02 ± 0.51 |
| Hb (g/l) | 78.73 ± 17.77 |
| WBC (× 109/L) | 2.86 (2.04–3.91) |
| PLT (× 109/L) | 105.00 (57.00–159.00) |
| ALT (U/L) | 22.55 ± 9.48 |
| AST (U/L) | 30.09 ± 11.85 |
| TBIL (μmol/L) | 21.30 (15.90–32.90) |
| ALB (g/l) | 32.37 ± 5.95 |
| BUN(mmol/L) | 6.42 ± 2.39 |
| Cr(μmol/L) | 60.30 ± 15.12 |
| Na+(mmol/L) | 137.86 ± 5.84 |
| PT (s) | 14.90 (13.45–16.18) |
| INR | 1.37 (1.18–1.47) |
| APTT (s) | 32.76 ± 6.80 |
| CP score | 7.96 ± 1.89 |
| MELD score | 9.92 ± 5.23 |
Data are presented as mean ± standard deviation, median (interquartile range,IQR) or n (%). CP score Child–Pugh score, MELD model for end-stage liver disease